|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mello CC and Conte D Jr: Revealing the
world of RNA interference. Nature. 431:338–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu JF, Zhao SH and Wu SS: Depleting NFAT1
expression inhibits the ability of invasion and migration of human
lung cancer cells. Cancer Cell Int. 13:412013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martens-de Kemp SR, Nagel R, Stigter-van
Walsum M, van der Meulen IH, van Beusechem VW, Braakhuis BJ and
Brakenhoff RH: Functional genetic screens identify genes essential
for tumor cell survival in head and neck and lung cancer. Clin
Cancer Res. 19:1994–2003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Tian H, Yue W, Li L, Gao C, Si L, Li
W, Hu W, Qi L and Lu M: Down-regulation of MTA1 protein leads to
the inhibition of migration, invasion, and angiogenesis of
non-small-cell lung cancer cell line. Acta Biochim Biophys Sin
(Shanghai). 45:115–122. 2013. View Article : Google Scholar
|
|
7
|
Tone Y, Tanahashi N, Tanaka K, Fujimuro M,
Yokosawa H and Toh-E A: Nob1p, a new essential protein, associates
with the 26S proteasome of growing Saccharomyces cerevisiae cells.
Gene. 243:37–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tone Y and Toh-E A: Nob1p is required for
biogenesis of the 26S proteasome and degraded upon its maturation
in Saccharomyces cerevisiae. Genes Dev. 16:3142–3157. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fatica A, Tollervey D and Dlakić M: PIN
domain of Nob1p is required for D-site cleavage in 20S pre-rRNA.
RNA. 10:1698–1701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lamanna AC and Karbstein K: Nob1 binds the
single-stranded cleavage site D at the 3′-end of 18S rRNA with its
PIN domain. Proc Natl Acad Sci USA. 106:14259–14264. 2009.
View Article : Google Scholar
|
|
11
|
Clissold PM and Ponting CP: PIN domains in
nonsense-mediated mRNA decay and RNAi. Curr Biol. 10:R888–R890.
2000. View Article : Google Scholar
|
|
12
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang WY, Chen DH, Ning L and Wang LW:
siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog
inhibits proliferation and growth of breast cancer cells. Asian Pac
J Cancer Prev. 13:1823–1827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated down-regulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar
|
|
16
|
Tomar RS, Matta H and Chaudhary PM: Use of
adeno-associated viral vector for delivery of small interfering
RNA. Oncogene. 22:5712–5715. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan J, Yan R, Krämer A, Eckerdt F, Roller
M, Kaufmann M and Strebhardt K: Cyclin B1 depletion inhibits
proliferation and induces apoptosis in human tumor cells. Oncogene.
23:5843–5852. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang W, Chen X, Li T, Li Y, Wang R, He D,
Luo W, Li X and Wu X: Screening a phage display library for a novel
FGF8b-binding peptide with anti-tumor effect on prostate cancer.
Exp Cell Res. 319:1156–1164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gartel AL and Tyner AL: The role of the
cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer
Ther. 1:639–649. 2002.PubMed/NCBI
|
|
20
|
Machuy N, Thiede B, Rajalingam K, Dimmler
C, Thieck O, Meyer TF and Rudel T: A global approach combining
proteome analysis and phenotypic screening with RNA interference
yields novel apoptosis regulators. Mol Cell Proteomics. 4:44–55.
2005. View Article : Google Scholar
|
|
21
|
Adams J: The proteasome: A suitable
antineoplastic target. Nat Rev Cancer. 4:349–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lehman NL: The ubiquitin proteasome system
in neuropathology. Acta Neuropathol. 118:329–347. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Clurman BE, Sheaff RJ, Thress K, Groudine
M and Roberts JM: Turnover of cyclin E by the ubiquitin-proteasome
pathway is regulated by cdk2 binding and cyclin phosphorylation.
Genes Dev. 10:1979–1990. 1996. View Article : Google Scholar : PubMed/NCBI
|
